UK markets open in 6 hours 12 minutes
  • NIKKEI 225

    26,661.18
    +16.47 (+0.06%)
     
  • HANG SENG

    26,905.92
    +11.24 (+0.04%)
     
  • CRUDE OIL

    45.08
    -0.45 (-0.99%)
     
  • GOLD FUTURES

    1,784.60
    -3.50 (-0.20%)
     
  • DOW

    29,910.37
    +37.87 (+0.13%)
     
  • BTC-GBP

    13,776.63
    +35.83 (+0.26%)
     
  • CMC Crypto 200

    362.93
    -7.58 (-2.05%)
     
  • ^IXIC

    12,205.85
    +350.85 (+2.96%)
     
  • ^FTAS

    3,593.68
    +4.64 (+0.13%)
     

Insights on the Breast Cancer Screening Market in North America to 2027 - by Test Type, End-user and Countries

Research and Markets
·9-min read

Dublin, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The "North America Breast Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Test Type; End User, and Countries" report has been added to ResearchAndMarkets.com's offering.

The North America breast cancer screening was valued at US$ 2,064.26 million in 2019 and is projected to reach US$ 2,832.04 million by 2027; it is expected to grow at CAGR of 5.1% from 2020 to 2027.

The growing prevalence of breast cancer, and the increasing number of investments and initiatives for breast cancer management are among the major factors driving the growth of the North America breast cancer screening market. However, high cost associated with breast cancer screening restrains the growth of the market.

Early detection helps reduce the cancer mortality rates; therefore, medical professionals, market players, and government authorities are implementing new diagnostic and treatment facilities. Hence, breast cancer screening plays a significant role in determining the suitable procedure and required pace of treatment. As per the Centers for Disease Control and Prevention (CDC), the CDC's Division of Cancer Prevention and Control, along with the state health agencies, tribes and tribal organizations, territories, and other essential organizations, develops and promotes the effective cancer prevention and control practices.

From the day of foundation, CDC's National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides convenient breast and cervical cancer screening and diagnostic services to low-income, uninsured, and underserved women. Moreover, in October 2019, the Breast Cancer Research Foundation (BCRF) funded breast cancer research for the year 2019-2020 by donating US$ 66 million to support the work of ~275 academics as well as scientists from leading medical institutions worldwide. Moreover, as per the American Recovery and Reinvestment Act of 2009 (ARRA), researches has been sponsored to understand and address the causes of cancer health inequalities. For instance, the Howard University Cancer Center and Johns Hopkins University Cancer Center have extended their partnership to conduct research on cancer screening, diagnosis, treatment, prevention, and supportive care, with focus on cancer incidence among African-Americans.

The North America breast cancer screening market is segmented on the basis of test type and end user. The market based on test type has been segmented into imaging test, Immunohistochemistry test, genetic test, and blood marker test. The imaging test segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. Based on end user, the North America breast cancer screening market is segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019; moreover, it is expected to register fastest growth during 2020-2027.

Cancer Center Amsterdam, Food and Drug Administration, World Health Organization (WHO), Centers for Disease Control and Prevention, and International Diabetes Federation are a few of the essential primary and secondary sources referred to for preparing this report.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the breast cancer screening market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the north america breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth north america market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Breast Cancer Screening Market - By Test Type
1.3.2 Global Breast Cancer Screening Market - By End User
1.3.3 North America Breast Cancer Screening Market- By Region

2. Breast Cancer Screening Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Breast Cancer Screening - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.3 Expert Opinion

5. North America Breast Cancer Screening Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Growing Prevalence of Breast Cancer
5.1.2 Growing Initiatives and Investments for Breast Cancer Management
5.2 Key Market Restraints
5.2.1 High Cost Associated With Breast Cancer Screening
5.3 Key Market Opportunities
5.3.1 Technological Advancements In Breast Imaging Modalities
5.4 Future Trends
5.4.1 Consistent Launch of New Screening Products
5.5 Impact Analysis

6. Breast Cancer Screening Market - Regional Analysis
6.1 North America Breast Cancer Screening Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players

7. Breast Cancer Screening Market Analysis - By Test Type
7.1 Overview
7.2 Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)
7.2.1 North America Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
7.3 Blood Marker Test
7.3.1 Overview
7.4 Blood Marker Tests: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Imaging Test
7.5.1 Overview
7.5.2 Imaging Test: Breast Cancer Screening Market- Revenue and Forecast to 2027 (US$ Million)
7.6 Genetic Test
7.6.1 Overview
7.6.2 Genetic Test: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Immunohistochemistry Test
7.7.1 Overview
7.7.2 Immunohistochemistry Test: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)

8. Breast Cancer Screening Market - By End User
8.1 Overview
8.2 Breast Cancer Screening Market, by End User, 2019 and 2027 (%)
8.2.1 North America Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostics Centers
8.4.1 Overview
8.4.2 Diagnostic Centers: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Research Laboratories
8.5.1 Overview
8.6 Research Laboratories: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Cancer Institutes
8.7.1 Overview
8.8 Cancer Institutes: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)

9. Breast Cancer Screening Market- Regional Analysis
9.1 North America: Breast Cancer Screening Market
9.1.1 Overview
9.1.2 North America: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.1.4 North America: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.1.5 North America: Breast Cancer Screening Market, by Country, 2019 & 2027 (%)
9.1.6 US: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.1.6.3 US: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.1.7 Canada: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.1.7.3 Canada: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.1.8 Mexico: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.1.8.3 Mexico: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)

10. Impact of COVID-19 Pandemic On North America Breast Cancer Screening Market
10.1 North America: Impact Assessment of COVID-19 Pandemic

11. Breast Cancer Screening Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Breast Cancer Screening Market, 2016-2020
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview

12. Breast Cancer Screening Market - Key Company Profiles
12.1 General Electric Company
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Siemens Healthineers AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Exact Sciences Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips N.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hologic, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BD
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Myriad Genetics, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Oncocyte Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Danaher
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 POC Medical Systems
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/6vxkm5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900